Andrea Cassingena
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda(IT)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Cancer Genomics and Diagnostics, Cancer Research and Treatments, Lung Cancer Treatments and Mutations, Genetic factors in colorectal cancer
Most-Cited Works
- → Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients(2015)1,079 cited
- → Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial(2016)993 cited
- → Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer(2013)658 cited
- → The genomic landscape of response to EGFR blockade in colorectal cancer(2015)490 cited
- → Erratum: Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients(2015)259 cited
- → Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer(2017)232 cited
- → Radiologic and Genomic Evolution of Individual Metastases during HER2 Blockade in Colorectal Cancer(2018)157 cited
- → Promoter CpG Island Hypermethylation of the DNA Repair Enzyme MGMT Predicts Clinical Response to Dacarbazine in a Phase II Study for Metastatic Colorectal Cancer(2013)127 cited
- → Digital PCR quantification of MGMT methylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancer(2015)123 cited
- → Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in BRAF -Mutant Colorectal Cancer(2016)120 cited